Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert M Langer

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Journal of Hepatology|February 14, 2012
The effect of steroid pretreatment of deceased organ donors on liver allograft function: a blinded randomized placebo-controlled trialStefan Amatschek, Julia Wilflingseder, Mario Pones, et al.
Pathology Oncology Research : POR|March 28, 2007
Malignancies after renal transplantation during 33 years at a single centerGyula Végso, Mária Tóth, Márta Hídvégi, et al.
Plos One|August 6, 2014
Molecular pathogenesis of post-transplant acute kidney injury: assessment of whole-genome mRNA and miRNA profilesJulia Wilflingseder, Judith Sunzenauer, Eva Toronyi, et al.
International Urology and Nephrology|November 26, 2011
Roma ethnicity and clinical outcomes in kidney transplant recipientsMiklos Z Molnar, Robert M Langer, Adam Remport, et al.
Transplantation|February 25, 2005
Methoxyethyl-modified intercellular adhesion molecule-1 antisense phosphorothiateoligonucleotides inhibit allograft rejection, ischemic-reperfusion injury, and cyclosporine-induced nephrotoxicityWenhau Chen, Robert M Langer, Slawa Janczewska, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|October 19, 2016
ADHERE: randomized controlled trial comparing renal function in de novo kidney transplant recipients receiving prolonged-release tacrolimus plus mycophenolate mofetil or sirolimusOleg O Rummo, Mario Carmellini, Lionel Rostaing, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 5, 2012
Everolimus plus early tacrolimus minimization: a phase III, randomized, open-label, multicentre trial in renal transplantationRobert M Langer, Ronald Hené, Stefan Vitko, et al.
Transplantation|July 13, 2010
Does borderline kidney allograft rejection always require treatment?Dorottya Németh, Jörg Ovens, Gerhard Opelz, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|February 18, 2018
Defining outcomes for β-cell replacement therapy in the treatment of diabetes: a consensus report on the Igls criteria from the IPITA/EPITA opinion leaders workshopMichael R Rickels, Peter G Stock, Eelco J P de Koning, et al.
Transplantation|March 13, 2018
Defining Outcomes for β-cell Replacement Therapy in the Treatment of Diabetes: A Consensus Report on the Igls Criteria From the IPITA/EPITA Opinion Leaders WorkshopMichael R Rickels, Peter G Stock, Eelco J P de Koning, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Journal of Hepatology|February 14, 2012
The effect of steroid pretreatment of deceased organ donors on liver allograft function: a blinded randomized placebo-controlled trialStefan Amatschek, Julia Wilflingseder, Mario Pones, et al.
Pathology Oncology Research : POR|March 28, 2007
Malignancies after renal transplantation during 33 years at a single centerGyula Végso, Mária Tóth, Márta Hídvégi, et al.
Plos One|August 6, 2014
Molecular pathogenesis of post-transplant acute kidney injury: assessment of whole-genome mRNA and miRNA profilesJulia Wilflingseder, Judith Sunzenauer, Eva Toronyi, et al.
International Urology and Nephrology|November 26, 2011
Roma ethnicity and clinical outcomes in kidney transplant recipientsMiklos Z Molnar, Robert M Langer, Adam Remport, et al.
Transplantation|February 25, 2005
Methoxyethyl-modified intercellular adhesion molecule-1 antisense phosphorothiateoligonucleotides inhibit allograft rejection, ischemic-reperfusion injury, and cyclosporine-induced nephrotoxicityWenhau Chen, Robert M Langer, Slawa Janczewska, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|October 19, 2016
ADHERE: randomized controlled trial comparing renal function in de novo kidney transplant recipients receiving prolonged-release tacrolimus plus mycophenolate mofetil or sirolimusOleg O Rummo, Mario Carmellini, Lionel Rostaing, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 5, 2012
Everolimus plus early tacrolimus minimization: a phase III, randomized, open-label, multicentre trial in renal transplantationRobert M Langer, Ronald Hené, Stefan Vitko, et al.
Transplantation|July 13, 2010
Does borderline kidney allograft rejection always require treatment?Dorottya Németh, Jörg Ovens, Gerhard Opelz, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|February 18, 2018
Defining outcomes for β-cell replacement therapy in the treatment of diabetes: a consensus report on the Igls criteria from the IPITA/EPITA opinion leaders workshopMichael R Rickels, Peter G Stock, Eelco J P de Koning, et al.
Transplantation|March 13, 2018
Defining Outcomes for β-cell Replacement Therapy in the Treatment of Diabetes: A Consensus Report on the Igls Criteria From the IPITA/EPITA Opinion Leaders WorkshopMichael R Rickels, Peter G Stock, Eelco J P de Koning, et al.
Pageof 3